Muestra la distribución de la producción WoS, Scopus y SciELO del autor.
Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.
| Firmas del autor | |
| Nombre | RIED, NICOLAS |
| Género | Hombre |
| Área Principal WOS | Ethics; Humanities, Multidisciplinary; History & Philosophy Of Science; |
| Afiliación Principal | Universidad De Chile |
Publicaciones en Chile
Citas Totales
Afiliaciones Chilenas
| WOS | #Pub |
|---|---|
| Ethics | 1 |
| Humanities, Multidisciplinary | 1 |
| History & Philosophy Of Science | 1 |
| Art | 1 |
| Film, Radio, Television | 1 |
| Scopus | #Pub |
|---|---|
| Arts And Humanities (All) | 2 |
| Social Sciences (All) | 1 |
| SciELO | #Pub |
|---|---|
| Human Sciences | 1 |
| Título | Año | Citas | Tipo | Revista | Indexada |
|---|---|---|---|---|---|
| Leni Riefenstahl | 2018 | 0 | revisión libro | Fotocinema Revista Cientifica De Cine Y Fotografia | WoS Scopus |
| Towards A Genealogy Of Pharmacological Practice | 2016 | 6 | artículo de investigación | Medicine, Healthcare And Philosophy | WoS Scopus |
| The Invention Of Drug Addict As Subject To Correct. The Figure Of Drug Addict In The Chilean Pharmaceutical Discursive Production Of The First Half Of The 20th Century | 2019 | 0 | artículo de investigación | Universum (Talca) Revista De Humanidades Y Ciencias Sociales | WoS SciELO Scopus |
| Resistance To Molecular Biopower | 2020 | 0 | artículo de investigación | Alpha | WoS Scopus |
| Palabra Clave | #Pub |
|---|---|
| biopolitics | 2 |
| health | 1 |
| xenical | 1 |
| weight-loss | 1 |
| toxicomanía | 1 |
| testosterone | 1 |
| sociological understandings | 1 |
| self-care | 1 |
| resistance | 1 |
| pro-ana | 1 |
| pharmacology | 1 |
| pharmacological practice | 1 |
| pharmaceutical-industry | 1 |
| patient | 1 |
| molecular politics | 1 |
| abnormals | 1 |
| genealogy | 1 |
| foucault | 1 |
| farmacología | 1 |
| expert patients | 1 |
| empowerment | 1 |
| drug addicts | 1 |
| disease | 1 |
| disciplinary power | 1 |
| biopower | 1 |
| biopolítica | 1 |
| big pharma | 1 |
| anormales | 1 |